1. Home
  2. CMC vs SYRE Comparison

CMC vs SYRE Comparison

Compare CMC & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commercial Metals Company

CMC

Commercial Metals Company

HOLD

Current Price

$67.18

Market Cap

7.5B

Sector

Industrials

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$90.72

Market Cap

8.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMC
SYRE
Founded
1915
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5B
8.5B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
CMC
SYRE
Price
$67.18
$90.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
12
Target Price
$73.33
$85.08
AVG Volume (30 Days)
970.5K
1.0M
Earning Date
03-26-2026
05-08-2026
Dividend Yield
1.20%
N/A
EPS Growth
N/A
N/A
EPS
3.96
N/A
Revenue
$7,918,430,000.00
N/A
Revenue This Year
$18.81
N/A
Revenue Next Year
$6.34
N/A
P/E Ratio
$17.42
N/A
Revenue Growth
25.57
N/A
52 Week Low
$53.08
$14.51
52 Week High
$84.87
$110.18

Technical Indicators

Market Signals
Indicator
CMC
SYRE
Relative Strength Index (RSI) 43.40 37.78
Support Level $65.30 $82.83
Resistance Level $72.41 $106.10
Average True Range (ATR) 2.11 4.23
MACD -0.00 -1.29
Stochastic Oscillator 29.13 15.03

Price Performance

Historical Comparison
CMC
SYRE

About CMC Commercial Metals Company

Commercial Metals Co is a manufacturer and supplier of early-stage construction materials, including steel reinforcing bars, concrete pipes, precast products, and soil stabilization solutions. It also produces merchant bar, steel fence posts, and wire rod, serving domestic and some international markets in Europe and Asia. Its products are used in infrastructure and building projects such as highways, bridges, airports, and commercial and residential buildings.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: